Cargando…

Sequence symmetry analysis graphic adjustment for prescribing trends

BACKGROUND: Sequence symmetry analysis (SSA) is a signal detection method that can be used to assist with adverse drug event detection. It provides both a risk estimate and a data visualisation. Published methods provide results in the form of an adjusted sequence ratio, which adjusts for underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: Preiss, Adrian Kym, Roughead, Elizabeth Ellen, Pratt, Nicole Leanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617934/
https://www.ncbi.nlm.nih.gov/pubmed/31288743
http://dx.doi.org/10.1186/s12874-019-0781-1
_version_ 1783433805705510912
author Preiss, Adrian Kym
Roughead, Elizabeth Ellen
Pratt, Nicole Leanne
author_facet Preiss, Adrian Kym
Roughead, Elizabeth Ellen
Pratt, Nicole Leanne
author_sort Preiss, Adrian Kym
collection PubMed
description BACKGROUND: Sequence symmetry analysis (SSA) is a signal detection method that can be used to assist with adverse drug event detection. It provides both a risk estimate and a data visualisation. Published methods provide results in the form of an adjusted sequence ratio, which adjusts for underlying market trends of medicine use, however no method for adjusting the visualisation is available. We aimed to develop and evaluate another method of adjustment for prescribing trends and apply it to the SSA visualisation. METHODS: The SSA method relies on incident prescriptions for pairs of medicines of interest. Smoothing curves were fitted to the frequency distributions of incident medicine use. When divided and normalised, these curves yielded a set of proportions related to differences in prescribing trends over follow-up. These were then used to adjust the unit counts for incident prescriptions in the SAA visualisation and to calculate the sequence ratio. Curve fitting was also used to identify the proportional relationship between sequences over time for SSA and is presented as a supplementary visualisation to the SSA. We compared the sensitivity and specificity of our method with that from the SSA method of Tsiropolous et al. RESULTS: Curve-fit adjusted SSA visualisations yielded adjusted sequence ratios very close to those of Tsiropolous, with a p-value of 0.999 for the two sample Kolmogorov-Smirnov test. Results for sensitivity and specificity derived from adjusted sequence ratios were also practically the same. The curve-fit method graphically indicates the proportionality of the sequence and provides a useful supplement of net differences between the two sides of the SSA visualisation. Additionally, we found that incident prescriptions for patients common to both distributions are best precluded from adjustment calculations, leaving only incident prescriptions for patients unique to one or other distribution. This improved the accuracy of SSA in some atypical instances with negligible affect on accuracy elsewhere. CONCLUSIONS: Our curve-fit method is equivalent to current methods in the literature for adjusting prescribing trends in SAA, with the advantage of providing adjustment incorporated in the SAA visualisation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-019-0781-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6617934
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66179342019-07-22 Sequence symmetry analysis graphic adjustment for prescribing trends Preiss, Adrian Kym Roughead, Elizabeth Ellen Pratt, Nicole Leanne BMC Med Res Methodol Research Article BACKGROUND: Sequence symmetry analysis (SSA) is a signal detection method that can be used to assist with adverse drug event detection. It provides both a risk estimate and a data visualisation. Published methods provide results in the form of an adjusted sequence ratio, which adjusts for underlying market trends of medicine use, however no method for adjusting the visualisation is available. We aimed to develop and evaluate another method of adjustment for prescribing trends and apply it to the SSA visualisation. METHODS: The SSA method relies on incident prescriptions for pairs of medicines of interest. Smoothing curves were fitted to the frequency distributions of incident medicine use. When divided and normalised, these curves yielded a set of proportions related to differences in prescribing trends over follow-up. These were then used to adjust the unit counts for incident prescriptions in the SAA visualisation and to calculate the sequence ratio. Curve fitting was also used to identify the proportional relationship between sequences over time for SSA and is presented as a supplementary visualisation to the SSA. We compared the sensitivity and specificity of our method with that from the SSA method of Tsiropolous et al. RESULTS: Curve-fit adjusted SSA visualisations yielded adjusted sequence ratios very close to those of Tsiropolous, with a p-value of 0.999 for the two sample Kolmogorov-Smirnov test. Results for sensitivity and specificity derived from adjusted sequence ratios were also practically the same. The curve-fit method graphically indicates the proportionality of the sequence and provides a useful supplement of net differences between the two sides of the SSA visualisation. Additionally, we found that incident prescriptions for patients common to both distributions are best precluded from adjustment calculations, leaving only incident prescriptions for patients unique to one or other distribution. This improved the accuracy of SSA in some atypical instances with negligible affect on accuracy elsewhere. CONCLUSIONS: Our curve-fit method is equivalent to current methods in the literature for adjusting prescribing trends in SAA, with the advantage of providing adjustment incorporated in the SAA visualisation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-019-0781-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-09 /pmc/articles/PMC6617934/ /pubmed/31288743 http://dx.doi.org/10.1186/s12874-019-0781-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Preiss, Adrian Kym
Roughead, Elizabeth Ellen
Pratt, Nicole Leanne
Sequence symmetry analysis graphic adjustment for prescribing trends
title Sequence symmetry analysis graphic adjustment for prescribing trends
title_full Sequence symmetry analysis graphic adjustment for prescribing trends
title_fullStr Sequence symmetry analysis graphic adjustment for prescribing trends
title_full_unstemmed Sequence symmetry analysis graphic adjustment for prescribing trends
title_short Sequence symmetry analysis graphic adjustment for prescribing trends
title_sort sequence symmetry analysis graphic adjustment for prescribing trends
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617934/
https://www.ncbi.nlm.nih.gov/pubmed/31288743
http://dx.doi.org/10.1186/s12874-019-0781-1
work_keys_str_mv AT preissadriankym sequencesymmetryanalysisgraphicadjustmentforprescribingtrends
AT rougheadelizabethellen sequencesymmetryanalysisgraphicadjustmentforprescribingtrends
AT prattnicoleleanne sequencesymmetryanalysisgraphicadjustmentforprescribingtrends